Second-line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study
- 31 January 2000
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 27 (1) , 47-53
- https://doi.org/10.1016/s0169-5002(99)00092-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Phase II study of combination weekly gemcitabine and vinorelbine in patients with untreated or previously treated non-small cell lung cancerLung Cancer, 2000
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Docetaxel in stage III and IV non-small cell lung cancerEuropean Journal Of Cancer, 1995
- Second-line with vinorelbine in the weekly monochemotherapy for the treatment of advanced non small cell lung cancer (NSCLC)Lung Cancer, 1994
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI Journal of the National Cancer Institute, 1993
- Chemotherapy of Lung CancerNew England Journal of Medicine, 1992
- New concepts on histopathology of Hodgkin's diseaseAnnals of Oncology, 1992
- Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancerCancer Chemotherapy and Pharmacology, 1992
- Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and-resistant human ovarian carcinoma cell linesCancer Chemotherapy and Pharmacology, 1992